Top compounds associated with response to ASXL3


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.069 0.1
mRNA tivozanib GDSC1000 pan-cancer AAC 0.057 0.1
mRNA tivozanib CTRPv2 pan-cancer AAC -0.0089 0.8
mRNA tosedostat CTRPv2 pan-cancer AAC 0.045 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.053 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 8e-05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.035 0.2
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.12 0.002
mRNA triptolide CTRPv2 pan-cancer AAC 0.066 0.06
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.1 0.002
Download CSV